1 Followers on Owler

IDRx

is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops precision therapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

IDRx

is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops precision therapies for the treatment of cancer... Read more
IDRx CEO: Tim Clackson

CEO

Tim Clackson

CEO Approval Rating

90/100

2021

PrivateAcquired by GSK plc

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$242M

News

Acquisition
Jan 13, 2025
Business Wire
IDRx Was acquired by GSK plc for $1B
Funding
Aug 07, 2024
Pharamceutical Technology
IDRx received $120M in Series B Funding

IDRx Competitors

1Karyopharm Therapeutics
2Kite Pharma
3Kura
4Mustang Bio
5NexImmune
6Juno Therapeutics
7Getwell Oncology
Unlock 4 + competitors

Trending Companies